Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO World Congress on Gastrointestinal Cancer

Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients

Impact of single heterozygous UGT1A1 on the clinical outcomes of nano-liposomal irinotecan plus 5-fluorouracil/leucovorin for patients with pancreatic ductal adenocarcinoma

Date

01 Jul 2022

Session

Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients

Topics

Tumour Site

Pancreatic Adenocarcinoma

Presenters

Kazuaki Harada, Japan

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Discussant: SO-29, SO-30

Presenter: Harpreet Wasan, United Kingdom

Session: Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients

Resources:

Slides

Cardiac Toxicities

Presenter: Pia Osterlund, Finland

Session: Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients

Resources:

Slides

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.